Cornea - ARVO

More documents

Recommendations

Info

ARVO 2013 Annual Meeting Abstracts by Scientific Section/Group - Corneaform stable crosslinked products and is an effective crosslinkingagent for Descemet membrane fixation. Therefore, these resultsindicated that the genipin-fixed Descemet membrane may be appliedas a excellent culture carrier. The non-toxic nature crosslinkergenipin may be useful for the application on the reconstruction of theocular surface.Commercial Relationships: Lung-Kun Yeh, None; Shih-ChunHuang, NoneSupport: Chang Medical Research Project G CMRPG3A1291 ;National Science Council Grants (Taiwan) 1012314B182A056MY3Program Number: 542 Poster Board Number: B0179Presentation Time: 10:30 AM - 12:15 PMThe Role of Nrf2-Mediated Defense System in Corneal EpithelialWound HealingRyuhei Hayashi 1 , Noriko Himori 2 , Keiko Taguchi 3 , Yuki Ishikawa 1 ,Kohji Uesugi 1 , Motokazu Tsujikawa 1 , Toru Nakazawa 2 , MasayukiYamamoto 3 , Kohji Nishida 1 . 1 Ophthalmology, Osaka UniversityMedical School, Suita, Japan; 2 Ophthalmology, Tohoku universityschool of medicine, Sendai, Japan; 3 Department of MedicalBiochemistry, Tohoku university school of medicine, Sendai, Japan.Purpose: The Nrf2-mediated defense system plays a central role inprotecting cells by activating genes against these types of stress. Inthe present study, we investigated the role of the Nrf2-mediateddefense system in corneal epithelial wound healing by using Nrf2-knockout (KO) mice.Methods: The corneal epithelium of wild type (WT) and Nrf2 KOmice were removed by treatment of n-heptanol for 1 minute underanesthesia. The epithelial defect was stained with 1% fluoresceinsolution and photographed at 0, 6, 12, 18, 24, 30, 36, 48, 60, and 72 hafter epithelial debridement. Injured corneas healed at various timepoints were subjected to immunohistochemistry with Ki-67and Nrf2antibody. Telomerase-immortalized corneal epithelial cell line(C/TERT) was used for cell migration assay and siRNA experiment.Results: Nrf2 was expressed in the corneal epithelium of WT mice,but not in KO mice. Observation of wounds after 24 h of healingrevealed that healing of the corneal epithelium was significantlydelayed in the Nrf2 KO mice, while Nrf2 was activated in the cornealepithelium of WT mice. Ki-67-staining revealed that the number ofKi-67-positive proliferation cells was significantly lower in the Nrf2KO mice than in the WT mice at 24-36 h after injury; however, thesenumbers were approximately equivalent by 48 h. To clarify the roleof Nrf2 during wound healing, we performed in vitro experiments ofsiRNA for Nrf2. The result showed that Nrf2 knock-downsignificantly delayed corneal epithelial cell migration.Conclusions: This study provides evidence that the Nrf2-mediateddefense system plays a crucial role in corneal epithelial woundhealing, by regulating the cell-migration activities of cornealepithelial cells.Commercial Relationships: Ryuhei Hayashi, None; NorikoHimori, None; Keiko Taguchi, None; Yuki Ishikawa, None; KohjiUesugi, None; Motokazu Tsujikawa, Shionogi & Co. (C), DaiichiSankyo Co. (F), Daiichi Sankyo Co. (R), Santen Co. (R), AMO Co.(R); Toru Nakazawa, Kowa Company Ltd. (F), Kowa CompanyLtd. (C); Masayuki Yamamoto, None; Kohji Nishida, Alcon (C),Alcon (F), HOYA (F), Senju (F), Pfizer (F), Santen (F), OsakaUniversity (P)Support: Grants-in-Aid for Scientific Research from the Ministry ofEducation, Culture, Sports, Science and Technology in JapanProgram Number: 543 Poster Board Number: B0180Presentation Time: 10:30 AM - 12:15 PMIncreased fragility and acceleration of migration of cornealepithelial cells in an epiplakin deficiencyMasahide Kokado 1 , Yuka Okada 1 , Kazushi Ishikawa 2 , HiromitsuShimada 2 , Sakuhei Fujiwara 2 , Masayasu Miyajima 3 , Shizuya Saika 1 .1 Department of Ophthalmology, Wakayama Medical University,Wakayama, Japan; 2 Department of Dermatology, Oita University,Oita, Japan; 3 Laboratory animal center, Wakayama MedicalUniversity, Wakayama, Japan.Purpose: Epiplakin is one of intermediate filament-relatedcomponents. To examine fragility and mechanism of migration ofcorneal epithelial cells in an epiplakin deficiency. We previouslyreported that the loss of epiplakin facilitates healing of a defect incorneal epithelium in mice (ARVO 2009), and epiplakin knockdownby Short-interfering RNA (siRNA) was accelerated the migration ofHCEC and suppressed TGFb1 activation of p38 and JNK signals(ARVO2012).Methods: (1) We used Epiplakin KO (KO) (n=4) and wild type(WT) (n=4). The corneal surface was gently brushed with a surgicalmicro-sponge. Then ultrathin sections were cut and observed undertransmission electron microscopy. (2) We ran real-time RT-PCR forcell-cell connection-related components in RNA samples obtainedfrom KO (n=12)and WT (n=12). (3)Effect of siRNA knockdown ofEPPK on E-cadherin expression was also studied in AV40-immortalized corneal epithelial cells by using western blotting.Results: (1)Transmission electron microscopy showed that eachlayer of the epithelial cells was well maintained following brushing ina WT epithelium although partial separation between cells of thesuperficial layer. In a KO epithelium one or two layer(s) of basal orsupra-basal epithelial cells were found to be in the original positionfollowing the treatment and upper layer cells were found to beremoved. (2)Real-time RT-PCR also showed that mRNA expressionof E-cadherin was suppressed by the loss of epiplakin, while that ofdesmoglein-1 or desmoplakin-1 was not affected by epiplakin geneknockout in a mouse cornea. (3)EPPK knockdown suppressed E-cadherin expression in the cells.Conclusions: The loss of epiplakin affects the corneal epitheliumintegrity. The mechanism of acceleration of cell migration in the KOcorneal epithelium is to be further investigated, although suppressionof expression of E-cadherin in the absence of EPPK might beincluded. The possibility of the potential corneal epitheliumdisturbance in the patient who has abnormalities to EPPK wassuggested.Commercial Relationships: Masahide Kokado, None; YukaOkada, None; Kazushi Ishikawa, None; Hiromitsu Shimada,None; Sakuhei Fujiwara, None; Masayasu Miyajima, None;Shizuya Saika, NoneProgram Number: 544 Poster Board Number: B0181Presentation Time: 10:30 AM - 12:15 PMTransfer of mucosal epithelial cells and extracellular matrix by agelatin matrix technique in vitroAllen Ho 1 , Li-Fang Wang 2 . 1 Jianguo School, Taipei, Taiwan;2 National Taiwan University, Taipei, Taiwan.Purpose: Poor connection and adhesion of epithelial cells tounderlying connective tissues is the basic defect of blister disease ofconjunctiva, skin, and mouth mucosal membrane such as ocularcicatricial pemphigoid. Transplantation of extracellular matrix(ECM) along with the autologous buccal mucosal epithelial cells maymodulate the survival and subsequent proliferation of transplantedepithelial cells. Thus, we have developed a technique to transfernative ECM with human mucosal epithelial cells in vitro.Methods: Confluent monolayer human mucosal epithelial cells in theculture plate was pretreated with 0.25% edetic acid for 15 minutes©2013, Copyright by the Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Go to iovs.org to access the version of record. For permissionto reproduce any abstract, contact the ARVO Office at arvo@arvo.org.
ARVO 2013 Annual Meeting Abstracts by Scientific Section/Group - Corneaand coated with a 800 μ layer of 20% gelatin. Patches of the mucosalepithelial cells were harvested and transferred to another cultureplate. Cell viability and the ability of the transferred cells toproliferate in culture were determined. The ECM transferred alongwith the cells was characterized by immunohistochemistry.Results: Human mucosal epithelial cells in culture can be harvestedas an organized cell patch with high efficiency (92.3 ± 4.5%) andhigh cell viability (89.5 ± 5.5%). Cells harvested from tissue cultureplates divided and became confluent within 21 days.Immunohistochemistry demonstrates that the transferred ECM alongcontains laminin and type IV collagen.Conclusions: We were able to harvest mucosal epithelial cells as anorganized monolayer from tissue culture plate along with theirintercellular extracellular matrix. This approach may provide apractical technique for isolating and transplanting cultivatedautologous epithelial cells to reconstruct the damaged ocular surfacein Steven-Johnson syndrome, chemical and thermal injury, and ocularcicatricial pemphigoid.Commercial Relationships: Allen Ho, None; Li-Fang Wang, NoneProgram Number: 545 Poster Board Number: B0182Presentation Time: 10:30 AM - 12:15 PMMedical management of limbal stem cell deficiency with antiinflammatorytherapy and tear film optimizationBryan Kim 1 , Pejman Bakhtiari 1 , Kamran Riaz 2 , Clara C. Chan 3 ,Jeffrey Welder 1 , Surendra Basti 2 , Ali R. Djalilian 1 . 1 Ophthalmology,University of Illinois Eye and Ear Infirmary, Chicago, IL;2 Ophthalmology, Northwestern University Feinberg School ofMedicine, Chicago, IL; 3 Ophthalmology, University of Toronto,Toronto, ON, Canada.Purpose: To characterize the clinical features and medicalmanagement of cases with limbal stem cell deficiency (LSCD) thatwere reversible with anti-inflammatory therapy.Methods: Retrospective case series of 23 patients (35 eyes) at 3tertiary referral centers who were seen between 2007 and 2011.These patients initially had clinical findings consistent with LSCDbut then had resolution of these findings with only medicalmanagement. Main outcome measures included comparison of ocularsurface findings during and after medical treatment and changes invisual acuity.Results: Mean patient age was 41 years (range, 18-77) with 9 malesand 14 females. Etiologies of LSCD included contact lens wear (27eyes), contact lens wear in the setting of ocular rosacea (3 eyes),benzalkonium chloride (BAK) toxicity (2 eyes), and idiopathic (3eyes). Clinical findings included progressive epitheliopathy withassociated opaque epithelium arising from the limbus, loss of limbalarchitecture, and late fluorescein staining in a wavy or whorl pattern.Extent of limbal disease involvement varied from 30 to 360 degreesof limbus, with the superior limbus as the most common site ofinvolvement (31 eyes). Medical management was initiated in allpatients who had persistent disease after 3 months of conservativemeasures (e.g. discontinuing contact lens wear). The treatmentsincluded: topical corticosteroids (11 eyes), topical cyclosporine (11eyes), topical vitamin A (6 eyes), doxycycline (3 eyes), and punctalocclusion (15 eyes). Following treatment, all 35 eyes achieved astable ocular surface and resolution of LSCD over a mean follow-upof 7.9 months (range, 2-36 months). 32 eyes experiencedimprovement in visual acuity from an initial mean log MAR of 0.363(20/46) to a post-treatment mean log MAR of 0.136 (20/27)(P
Page 2 and 3: ARVO 2013 Annual Meeting Abstracts
Page 10: ARVO 2013 Annual Meeting Abstracts
Page 74 and 75:
ARVO 2013 Annual Meeting Abstracts
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296 and 297:
Page 298 and 299:
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
Page 308 and 309:
Page 310 and 311:
Page 312 and 313:
Page 314 and 315:
Page 316 and 317:
Page 318 and 319:
Page 320 and 321:
Page 322 and 323:
Page 324 and 325:
Page 326 and 327:
Page 328 and 329:
Page 330 and 331:
Page 332 and 333:
Page 334 and 335:
Page 336 and 337:
Page 338 and 339:
Page 340 and 341:
Page 342 and 343:
Page 344 and 345:
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
Page 380 and 381:
Page 382 and 383:
show all

Cornea - ARVO

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?